Point-of-Care Infectious Disease Diagnostics & Testing Market Report – Research, Industry Analysis Reports and Market Demands

(Post-pandemic Era)-Global Point-of-Care Infectious Disease Diagnostics & Testing Market Segment Research Report 2022

Request for Sample of this report

Buy now

Table of Content

Global Point-of-Care Infectious Disease Diagnostics & Testing Market Segment Research Report 2022

1. Research Scope

2. Market Overview

2.1 Product Introduction, Application, Picture
2.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Market by Value
- 2.2.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Type
- 2.2.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Market by Value (%)
2.3 Global Point-of-Care Infectious Disease Diagnostics & Testing Market by Production
- 2.3.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Production by Type
- 2.3.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Market by Production (%)

3. The Major Driver of Point-of-Care Infectious Disease Diagnostics & Testing Industry

3.1 Historical & Forecast Global Point-of-Care Infectious Disease Diagnostics & Testing Demand
3.2 Largest Application for Point-of-Care Infectious Disease Diagnostics & Testing (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Point-of-Care Infectious Disease Diagnostics & Testing Market

4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Point-of-Care Infectious Disease Diagnostics & Testing Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Point-of-Care Infectious Disease Diagnostics & Testing Production, Demand (2018-2028)

5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Demand Breakdown by Type
5.3 Current and Estimated Demand Breakdown by Application
5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Point-of-Care Infectious Disease Diagnostics & Testing Production, Demand (2018-2028)

6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Demand Breakdown by Type
6.3 Current and Estimated Demand Breakdown by Application
6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Point-of-Care Infectious Disease Diagnostics & Testing Production, Demand (2018-2028)

7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Demand Breakdown by Type
7.3 Current and Estimated Demand Breakdown by Application
7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Point-of-Care Infectious Disease Diagnostics & Testing Production, Demand (2018-2028)

8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Demand Breakdown by Type
8.3 Current and Estimated Demand Breakdown by Application
8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Point-of-Care Infectious Disease Diagnostics & Testing Production, Demand (2018-2028)

9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Demand Breakdown by Type
9.3 Current and Estimated Demand Breakdown by Application
9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Point-of-Care Infectious Disease Diagnostics & Testing Production, Demand (2018-2028)

10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Demand Breakdown by Type
10.3 Current and Estimated Demand Breakdown by Application
10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Point-of-Care Infectious Disease Diagnostics & Testing Production, Demand (2018-2028)

11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Demand Breakdown by Type
11.3 Current and Estimated Demand Breakdown by Application
11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Point-of-Care Infectious Disease Diagnostics & Testing Average Price Trend

12.1 Market Price for Each Type of Point-of-Care Infectious Disease Diagnostics & Testing in US (2018-2022)
12.2 Market Price for Each Type of Point-of-Care Infectious Disease Diagnostics & Testing in Europe (2018-2022)
12.3 Market Price for Each Type of Point-of-Care Infectious Disease Diagnostics & Testing in China (2018-2022)
12.4 Market Price for Each Type of Point-of-Care Infectious Disease Diagnostics & Testing in Japan (2018-2022)
12.5 Market Price for Each Type of Point-of-Care Infectious Disease Diagnostics & Testing in India (2018-2022)
12.6 Market Price for Each Type of Point-of-Care Infectious Disease Diagnostics & Testing in Korea (2018-2022)
12.7 Market Price for Each Type of Point-of-Care Infectious Disease Diagnostics & Testing in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)

13.1 Point-of-Care Infectious Disease Diagnostics & Testing Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Point-of-Care Infectious Disease Diagnostics & Testing

14. Point-of-Care Infectious Disease Diagnostics & Testing Competitive Landscape

15. Conclusion

16. Methodology and Data Source

Description

Summary

The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.

2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.

According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.

Beijing Yanjing Bizhi Information Consulting Co., Ltd. （XYZResearch）released the 《(Post-pandemic Era)-Global Point-of-Care Infectious Disease Diagnostics & Testing Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Point-of-Care Infectious Disease Diagnostics & Testing industry at home and abroad, estimate the overall market scale of the Point-of-Care Infectious Disease Diagnostics & Testing industry and the market share of major countries, Point-of-Care Infectious Disease Diagnostics & Testing industry, and study and judge the downstream market demand of Point-of-Care Infectious Disease Diagnostics & Testing through systematic research, Analyze the competition pattern of Point-of-Care Infectious Disease Diagnostics & Testing, so as to help solve the pain points of various stakeholders in Point-of-Care Infectious Disease Diagnostics & Testing industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.

Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Point-of-Care Infectious Disease Diagnostics & Testing Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Point-of-Care Infectious Disease Diagnostics & Testing Market?
Abbott
Thermo Fisher Scientific Inc
Roche
Siemens Healthineers
BD & Company
Chembio Diagnostics Inc.
Trinity Biotech
Cardinal Health
Quest Diagnostics Inc.
Bio-Rad Labs Inc.
bioMérieux SA
Sight Diagnostics Ltd.
Gene POC
Trivitron Healthcare
OJ-Bio Ltd.
Ortho-Clinical Diagnostics
Major Type of Point-of-Care Infectious Disease Diagnostics & Testing Covered in XYZResearch report:
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
Other Infectious Disease POC
Application Segments Covered in XYZResearch Market
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others

For any other requirements, please feel free to contact us and we will provide you customized report.